Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Marco Ladetto, Katja Gutmair, Jeanette K Doorduijn, Eva Gine, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke KJ Vergote, Piero Maria Stefani, Netanel A. Horowitz, Maria Gomes da Silva, Sirpa Leppä, Linmiao Jiang, Christiane Pott, Wolfram Klapper, Christian Schmidt, Michael Unterhalt, Martin Dreyling, Eva Hoster
Institutions: Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Ludwig-Maximilians-Universität München, Erasmus MC, Erasmus MC Cancer Institute, Hospital Clínic de Barcelona, Skåne University Hospital, The Maria Sklodowska-Curie National Research Institute of Oncology, Rigshospitalet, Swiss Group For Clinical Cancer Research, Kantonsspital Graubünden, Oslo University Hospital, Charles University, General University Hospital in Prague, Universitair Ziekenhuis Leuven, Ca' Foncello Hospital, Technion – Israel Institute of Technology, Rambam Health Care Campus, Instituto Português de Oncologia Francisco Gentil, University of Helsinki, Helsinki University Hospital, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, University Hospital Schleswig-Holstein, LMU Klinikum
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405043238